Modeling the Effectiveness of Respiratory Protective Devices in Reducing Influenza Outbreak

Risk Analysis : an Official Publication of the Society for Risk Analysis
Jing YanMatthew R Myers

Abstract

Outbreaks of influenza represent an important health concern worldwide. In many cases, vaccines are only partially successful in reducing the infection rate, and respiratory protective devices (RPDs) are used as a complementary countermeasure. In devising a protection strategy against influenza for a given population, estimates of the level of protection afforded by different RPDs is valuable. In this article, a risk assessment model previously developed in general form was used to estimate the effectiveness of different types of protective equipment in reducing the rate of infection in an influenza outbreak. It was found that a 50% compliance in donning the device resulted in a significant (at least 50% prevalence and 20% cumulative incidence) reduction in risk for fitted and unfitted N95 respirators, high-filtration surgical masks, and both low-filtration and high-filtration pediatric masks. An 80% compliance rate essentially eliminated the influenza outbreak. The results of the present study, as well as the application of the model to related influenza scenarios, are potentially useful to public health officials in decisions involving resource allocation or education strategies.

References

Feb 10, 2004·Mathematical Biosciences·Simon A LevinJoshua B Plotkin
Mar 15, 2005·Journal of Occupational and Environmental Hygiene·Mark NicasAlan Hubbard
Nov 11, 2006·American Journal of Industrial Medicine·Y LiE Newton
Jan 27, 2007·Journal of the Royal Society, Interface·Gerardo ChowellLuís M A Bettencourt
Sep 14, 2007·Epidemiology and Infection·S-C Chen, C-M Liao
Jan 31, 2008·American Journal of Epidemiology·Fabrice CarratAlain-Jacques Valleron
Mar 28, 2008·PLoS Medicine·Joël MossongW John Edmunds
May 29, 2009·American Journal of Epidemiology·Sheng LiJames S Koopman
Feb 19, 2010·Journal of the Royal Society, Interface·Nikolaos I Stilianakis, Yannis Drossinos
Aug 26, 2010·American Journal of Infection Control·Keith T Diaz, Gerald C Smaldone
Sep 21, 2010·Journal of Occupational and Environmental Hygiene·Lisa M Brosseau
Nov 26, 2010·The Journal of Infection·Jan GraltonWilliam D Rawlinson
Dec 15, 2010·PloS One·William G LindsleyDonald H Beezhold
Dec 31, 2010·Journal of Virology·Laetitia Canini, Fabrice Carrat
Mar 1, 2007·Environmental Health and Preventive Medicine·Hiroyuki Furuya
Apr 3, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Mohamed Mohsen Mansour, Gerald C Smaldone
Jun 6, 2013·Nature Communications·Benjamin J CowlingJames Mark Simmerman
Aug 21, 2013·Journal of Medical Virology·Jan GraltonWilliam D Rawlinson
Sep 13, 2013·Journal of the Royal Society, Interface·Z Y HanQ Y Huang
Dec 20, 2014·Journal of Occupational and Environmental Hygiene·William G LindsleyDonald H Beezhold
Jun 30, 2016·Electromagnetic Biology and Medicine·Rong WangMingyu Song
Oct 5, 2016·Current Opinion in Chemical Biology·Takuya Hashimoto, Tomohisa Kuzuyama
Oct 19, 2016·Journal of Occupational and Environmental Hygiene·Suvajyoti GuhaMatthew R Myers

❮ Previous
Next ❯

Citations

Aug 22, 2020·Proceedings. Mathematical, Physical, and Engineering Sciences·Richard O J H StuttJohn Colvin
Jun 12, 2020·Brain, Behavior, and Immunity·Yihui GohVijay K Sharma
Jan 30, 2021·Frontiers in Medicine·Daniela CoclitePrimiano Iannone
Jan 13, 2021·Proceedings of the National Academy of Sciences of the United States of America·Jeremy HowardAnne W Rimoin
Apr 27, 2021·Physics of Fluids·Nicola SerraConsolato M Sergi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Yaron FinkelsteinStephen B Freedman
JAMA : the Journal of the American Medical Association
Neville Clynes
JAMA : the Journal of the American Medical Association
Ted E Palen, Kate G Felix
JAMA : the Journal of the American Medical Association
Roger Bitar
American Journal of Respiratory and Critical Care Medicine
Mary T BessesenLewis J Radonovich
© 2022 Meta ULC. All rights reserved